Johns Hopkins ABX Guide
Cefazolin
Cefazolin is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Respiratory tract infections
- Due to S. pneumoniae, S. aureus (MSSA) and S. pyogenes
- Urinary tract infections
- Due to E. coli, P. mirabilis
- Prostatitis and epididymitis
- Due to E. coli, P. mirabilis
- Skin and skin-structure infections
- Due to S. aureus (MSSA), S. pyogenes, and other strains of streptococci
- Biliary tract infections
- Bone and joint infections due to S. aureus (MSSA)
- Septicemia
- Due to S. pneumoniae, S. aureus (MSSA), P. mirabilis, E. coli
- Endocarditis
- Due to S. aureus (MSSA) and S. pyogenes
- Perioperative prophylaxis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Parotitis (MSSA)
- Other Staphylococcus aureus (MSSA) infections
- Other Streptococcus pyogenes (Group A) infections
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Respiratory tract infections
- Due to S. pneumoniae, S. aureus (MSSA) and S. pyogenes
- Urinary tract infections
- Due to E. coli, P. mirabilis
- Prostatitis and epididymitis
- Due to E. coli, P. mirabilis
- Skin and skin-structure infections
- Due to S. aureus (MSSA), S. pyogenes, and other strains of streptococci
- Biliary tract infections
- Bone and joint infections due to S. aureus (MSSA)
- Septicemia
- Due to S. pneumoniae, S. aureus (MSSA), P. mirabilis, E. coli
- Endocarditis
- Due to S. aureus (MSSA) and S. pyogenes
- Perioperative prophylaxis
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Parotitis (MSSA)
- Other Staphylococcus aureus (MSSA) infections
- Other Streptococcus pyogenes (Group A) infections
There's more to see -- the rest of this entry is available only to subscribers.
Last updated: December 4, 2016
Citation
Avdic, Edina, and Paul A Pham. "Cefazolin." Johns Hopkins ABX Guide, The Johns Hopkins University, 2016. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540087/all/Cefazolin.
Avdic E, Pham PA. Cefazolin. Johns Hopkins ABX Guide. The Johns Hopkins University; 2016. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540087/all/Cefazolin. Accessed June 28, 2022.
Avdic, E., & Pham, P. A. (2016). Cefazolin. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540087/all/Cefazolin
Avdic E, Pham PA. Cefazolin [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2016. [cited 2022 June 28]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540087/all/Cefazolin.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cefazolin
ID - 540087
A1 - Avdic,Edina,Pharm.D.
AU - Pham,Paul,Pharm.D.
Y1 - 2016/12/04/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540087/all/Cefazolin
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
